Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Long-term Use of Stimulants for ADHD and Other Conditions

Evidence for Long-term Stimulant Use

  • The American Academy of Child and Adolescent Psychiatry recommends that stimulant medications can be used indefinitely for ADHD and other indicated conditions, with evidence showing maintained efficacy over extended periods as long as the medication continues to be taken and regular monitoring occurs 1
  • Prospective, longer-duration randomized controlled trials lasting 12-24 months have demonstrated that stimulants maintain their effectiveness over time with no diminution of efficacy 2
  • The NIMH Collaborative Multisite Multimodal Treatment Study of Children With ADHD (MTA study) showed that stimulants lead to stable improvements in ADHD symptoms as long as the drug continues to be taken 1
  • Studies lasting up to 24 months have shown persistence of medication effects over time, with children with ADHD continuing to respond well to methylphenidate treatment with no sign of diminishing efficacy 2
  • When medication is discontinued, its effects typically cease, although one double-blind discontinuation study found that ADHD-symptom reduction from 15 months of treatment with dextroamphetamine continued after the drug was stopped 3

Indications for Long-term Stimulant Use

  • The American Academy of Child and Adolescent Psychiatry indicates that ADHD (children, adolescents, and adults) with moderate to severe impairment in at least two different settings is an appropriate indication for long-term stimulant use 1
  • ADHD comorbid with conduct disorder is also an appropriate indication for long-term stimulant use, according to the American Academy of Child and Adolescent Psychiatry 4
  • Narcolepsy is another indication for long-term stimulant use, as stimulants significantly reduce daytime sleepiness 2
  • Apathy and depression in medically ill patients can also be treated with stimulants, though at lower doses than those used for ADHD 2

Monitoring Requirements for Indefinite Use

  • Regular assessment of continued efficacy using standardized rating scales is necessary for indefinite use of stimulants 5
  • Monitoring of vital signs, such as blood pressure and heart rate, is also required, as stimulants can affect these parameters 5
  • Tracking growth parameters in children and adolescents is necessary, as stimulants can affect weight and height 5
  • Periodic reassessment of medication necessity is essential to confirm continued appropriateness of stimulant therapy 5
  • Evaluation of overall impact on quality of life and functional impairment, not just symptom reduction, is also necessary 5

Formulation Considerations for Long-term Use

  • Long-acting formulations may improve adherence with once-daily dosing compared to multiple daily doses required with immediate-release preparations 6
  • Extended-release formulations help avoid the "roller-coaster effect" of immediate-release stimulants and reduce the need for in-school dosing 7

Potential Concerns with Indefinite Use

  • Limited systematic assessment of very long-term outcomes beyond 24 months is a concern with indefinite use of stimulants 6
  • Need for regular monitoring of potential side effects, including cardiovascular effects and growth parameters, is necessary 5
  • Risk of diversion and abuse, particularly with immediate-release formulations, is a concern with indefinite use of stimulants 1
  • Medication adherence challenges over extended periods can also be a concern 6

Clinical Approach to Long-term Management

  • Approximately 70% of patients respond to either methylphenidate or amphetamine, with up to 90% responding to at least one when both classes are tried 5
  • Regular reassessment is essential to confirm continued appropriateness of stimulant therapy and adjust dosing as needed 5

Common Pitfalls to Avoid

  • Failure to monitor for side effects or assess continued need for medication can lead to unnecessary long-term medication use 5
  • Discontinuing effective medication prematurely when it continues to provide benefit can also be a pitfall 2

Long‑Term Management and Monitoring of Methylphenidate Therapy

Efficacy and Need for Periodic Reassessment

  • Observational data from the Multimodal Treatment Study of Children with ADHD (MTA) indicate that children who continued psychostimulant therapy for more than 10 years did not achieve better clinical outcomes than those who discontinued, supporting the recommendation for regular reassessment of the need for ongoing medication rather than automatic indefinite continuation. 8

  • The same MTA analysis advises that clinicians should periodically evaluate the necessity of continued methylphenidate treatment and consider medication‑free intervals when appropriate. 8

Growth Monitoring Requirements

  • Current pediatric practice guidelines require that height and weight be measured at least once per year and plotted on standardized growth charts for all patients receiving long‑term methylphenidate, with treatment interruption considered if growth trajectories fall below expected ranges. 9

REFERENCES

5

Switching to Serdexmethylphenidate/Dexmethylphenidate for ADHD [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025